Skip to main content
. 2023 Mar 13;2023(3):CD010472. doi: 10.1002/14651858.CD010472.pub3

Comparison 1. Device‐modified trabeculectomy (trab) versus trabeculectomy.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1.1 Postoperative intraocular pressure (IOP) at 1 year by device type 6   Mean Difference (IV, Random, 95% CI) Subtotals only
1.1.1 Ex‐PRESS + trab versus trab 5 213 Mean Difference (IV, Random, 95% CI) ‐1.76 [‐2.81, ‐0.70]
1.1.2 PreserFlo MicroShunt versus trab 1 446 Mean Difference (IV, Random, 95% CI) 3.20 [2.29, 4.11]
1.2 Change in IOP from baseline at 1 year 1   Mean Difference (IV, Random, 95% CI) Totals not selected
1.3 Postoperative IOP at 6 months by device type 6   Mean Difference (IV, Random, 95% CI) Subtotals only
1.3.1 Ex‐PRESS + trab versus trab 5 253 Mean Difference (IV, Random, 95% CI) ‐0.10 [‐1.40, 1.20]
1.3.2 PreserFlo MicroShunt versus trab 1 446 Mean Difference (IV, Random, 95% CI) 3.00 [1.62, 4.38]
1.4 Postoperative IOP at 2 years 3 212 Mean Difference (IV, Random, 95% CI) ‐1.38 [‐2.66, ‐0.09]
1.5 Change in IOP from baseline at 6 months 1 20 Mean Difference (IV, Random, 95% CI) 0.20 [‐5.46, 5.86]
1.6 Postoperative logMAR best‐corrected visual acuity at 1 year 3 110 Mean Difference (IV, Random, 95% CI) ‐0.04 [‐0.19, 0.10]
1.7 Proportion of participants who are drop‐free at 1 year by device type 3   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
1.7.1 Ex‐PRESS + trab versus trab 2 48 Risk Ratio (M‐H, Random, 95% CI) 2.04 [0.42, 9.82]
1.7.2 PreserFlo MicroShunt versus trab 1 509 Risk Ratio (M‐H, Random, 95% CI) 0.84 [0.77, 0.93]
1.8 Mean number of IOP lowering medications at 1 year by device type 4   Mean Difference (IV, Random, 95% CI) Subtotals only
1.8.1 Ex‐PRESS + trab versus trab 3 170 Mean Difference (IV, Random, 95% CI) ‐0.34 [‐0.62, ‐0.07]
1.8.2 PreserFlo MicroShunt versus trab 1 509 Mean Difference (IV, Random, 95% CI) 0.30 [0.11, 0.49]
1.9 Proportion of participants with IOP less than 5 mmHg (hypotony) or shallow anterior chamber by device type 7 868 Risk Ratio (M‐H, Random, 95% CI) 0.73 [0.46, 1.17]
1.9.1 Ex‐PRESS + trab versus trab 6 342 Risk Ratio (M‐H, Random, 95% CI) 0.92 [0.61, 1.39]
1.9.2 PreserFlo MicroShunt versus trab 1 526 Risk Ratio (M‐H, Random, 95% CI) 0.44 [0.25, 0.79]
1.10 Proportion of participants with bleb leakage by device type 6 840 Risk Ratio (M‐H, Random, 95% CI) 0.64 [0.40, 1.02]
1.10.1 Ex‐PRESS + trab versus trab 5 314 Risk Ratio (M‐H, Random, 95% CI) 0.99 [0.45, 2.16]
1.10.2 PreserFlo MicroShunt versus trab 1 526 Risk Ratio (M‐H, Random, 95% CI) 0.51 [0.28, 0.90]
1.11 Proportion of participants with reoperations for glaucoma by device type 5 720 Risk Ratio (M‐H, Random, 95% CI) 0.69 [0.24, 1.98]
1.11.1 Ex‐PRESS + trab versus trab 4 194 Risk Ratio (M‐H, Random, 95% CI) 0.34 [0.09, 1.26]
1.11.2 PreserFlo MicroShunt versus trab 1 526 Risk Ratio (M‐H, Random, 95% CI) 1.30 [0.77, 2.22]
1.12 Proportion of participants with cataract extraction by device type 5 820 Risk Ratio (M‐H, Random, 95% CI) 0.46 [0.27, 0.80]
1.12.1 Ex‐PRESS + trab versus trab 4 294 Risk Ratio (M‐H, Random, 95% CI) 0.34 [0.14, 0.80]
1.12.2 PreserFlo MicroShunt versus trab 1 526 Risk Ratio (M‐H, Random, 95% CI) 0.57 [0.28, 1.17]
1.13 Proportion of participants with endophthalmitis 1 120 Risk Ratio (M‐H, Random, 95% CI) 0.34 [0.01, 8.29]
1.14 Proportion of participants with loss of vision of > 2 lines or loss of light perception 1 526 Risk Ratio (M‐H, Random, 95% CI) 0.57 [0.30, 1.07]